Literature DB >> 25691107

[Differential diagnosis of elevated liver transaminases in rheumatic diseases].

W-J Mayet1.   

Abstract

During laboratory monitoring of patients with rheumatic diseases it is not uncommon to notice elevated liver transaminase levels. From a rheumatological perspective there are multiple causes for this. Liver dysfunction can be the result of certain rheumatological diseases, such as systemic lupus erythematosus. Primary biliary cirrhosis and primary sclerosing cholangitis are associated with rheumatic diseases. On the other hand, hepatological diseases, such as hepatitis C and autoimmune hepatitis show rheumatological symptoms. The most common cause of elevation of liver transaminase levels in rheumatic patients is without doubt the anti-rheumatic therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25691107     DOI: 10.1007/s00393-014-1501-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  20 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Induction of immunological tolerance by porcine liver allografts.

Authors:  R Y Calne; R A Sells; J R Pena; D R Davis; P R Millard; B M Herbertson; R M Binns; D A Davies
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

Review 3.  Diverse manifestations and evolving treatments of autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Minerva Gastroenterol Dietol       Date:  2005-12

4.  [Methotrexate toxicity. Myths and facts].

Authors:  G Keysser
Journal:  Z Rheumatol       Date:  2011-02       Impact factor: 1.372

Review 5.  Hepatitis viruses under immunosuppressive agents.

Authors:  Y F Liaw
Journal:  J Gastroenterol Hepatol       Date:  1998-01       Impact factor: 4.029

6.  A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?

Authors:  J M Kremer; R Koff
Journal:  Semin Arthritis Rheum       Date:  1992-06       Impact factor: 5.532

Review 7.  [Liver and rheumatism].

Authors:  C Wiegard; A W Lohse
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

8.  Sjögren's syndrome in patients with primary biliary cirrhosis.

Authors:  E V Tsianos; J H Hoofnagle; P C Fox; M Alspaugh; E A Jones; D F Schafer; H M Moutsopoulos
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

Review 9.  Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma.

Authors:  Shigeru Kusumoto; Yasuhito Tanaka; Masashi Mizokami; Ryuzo Ueda
Journal:  Int J Hematol       Date:  2009-06-23       Impact factor: 2.490

10.  Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events.

Authors:  Paresh Jobanputra; Roshan Amarasena; Fiona Maggs; Dawn Homer; Simon Bowman; Elizabeth Rankin; Andrew Filer; Karim Raza; Ronald Jubb
Journal:  BMC Musculoskelet Disord       Date:  2008-04-11       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.